Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.
Robert T, Lano G, Resseguier N, Bobot M, Bouchouareb D, Burtey S, de Lamballerie X, Dhorne J, Dussol B, Duval A, Faraut J, Fourié T, Giaime P, Hallah M, Jaubert D, Jéhel O, Legris T, Liotatis S, Moal V, Ninove L, Pedinielli N, Pelletier M, Romeu-Giannoli M, Saba M, Sallée M, Samson L, Saveanu A, Scarfoglière V, Sebahoun P, Vial R, Von Kotze C, Brunet P, Lebrun G, Bataille S, Jourde-Chiche N. Robert T, et al. Among authors: dhorne j. Sci Rep. 2022 Jul 13;12(1):11972. doi: 10.1038/s41598-022-15913-0. Sci Rep. 2022. PMID: 35831388 Free PMC article.
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.
Crétel-Durand E, Nouguerède E, Le Caer H, Rousseau F, Retornaz F, Guillem O, Couderc AL, Greillier L, Norguet E, Cécile M, Boulahssass R, Le Caer F, Tournier S, Butaud C, Guillet P, Nahon S, Poudens L, Kirscher S, Loubière S, Diaz N, Dhorne J, Auquier P, Baumstarck K. Crétel-Durand E, et al. Among authors: dhorne j. Trials. 2017 Apr 12;18(1):174. doi: 10.1186/s13063-017-1894-7. Trials. 2017. PMID: 28403911 Free PMC article. Clinical Trial.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.